bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,takeda
#ims2022 #mmsm a meaningful discussion on griffin with excellent analysis by philippe moreau i agree- we need to be very careful when we call anything as standard of care. the standards for calling a new standard should be really high
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities. No COI